Novartis Ireland Ltd wishes to announce the discontinuation of Estraderm TTS 50mcg patches, pack size 8, from March 2009. This will not have any effect on Estraderm TTS 25mcg or 100mcg as they will continue to be produced.
Patients currently on Estraderm TTS 50mcg can be changed to Estradot 50mcg, without any inconvenience.
Please note that as of August 2009, Estracombi TTS will also be discontinued as Estraderm TTS 50mcg is used within the Estracombi TTS pack. Further information will be available nearer the discontinuation date in August 2009.
For more information, please contact the Novartis Medical Information Officer at (01) 2080633 or email email@example.com